Company intelligence / Profile preview

Aumapharma

Ownership: Private
Development stage: Other

Overview

Aumapharma was a US-based startup with expertise in respiratory drug development. It focused on consultancy for pharmaceutical companies developing inhaled therapies for cystic fibrosis, asthma, COPD, and related conditions. There is no public record of proprietary drugs reaching advanced clinical stages under the Aumapharma name.

Therapeutic areas: Pulmonology
Modalities: Small moleculeInhaled drug delivery
Industry: Consulting

Partnerships

Likely partnered with various pharma clients via consultancy work

Beyond the preview

Go deeper on Aumapharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aumapharma.

Explore the full profile